GFAP and Cognitive impairment: Among them, peripheral glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) have gained much traction for their ability to predict the risk of dementia in individuals with subjective cognitive decline and mild cognitive impairment, as well as dementia-specific mortality [15, 16].